Valeant Pharmaceuticals International

Type: Company
Name: Valeant Pharmaceuticals International
First reported 4 hours ago - Updated 39 mins ago - 2 reports

Allergan confirms receipt of Valeant Pharmaceuticals takeover bid

:01 in Pharmaceutical Company Restructures Allergan has confirmed that fellow healthcare firm Valeant Pharmaceuticals has launched a bid to acquire the company. The merger proposal values Allergan at almost $50 billion (29.78 billion pounds) and is unsolicited, ... [Published Zenopa - 39 mins ago]
First reported 16 hours ago - Updated 41 mins ago - 4 reports

TSX ends slightly lower as banks weigh Valeant pulls back

TORONTO (Reuters) - Canada's main stock index closed slightly lower on Wednesday as Valeant Pharmaceuticals International Inc shares pulled back after an acquisition-backed bump the day before ... ... [Published Big News Network - 41 mins ago]
First reported 21 hours ago - Updated 2 hours ago - 16 reports

Allergan resists Valeant's advances

It looks like Valeant will have to work a lot harder to consummate its proposed $45.7bn marriage with Allergan, after its intended agreed to implement a 'poison pill' defense.Allergan's board voted in favour of a shareholder rights plan that gives existing ... [Published PMLive - 2 hours ago]
First reported Apr 23 2014 - Updated 2 hours ago - 6 reports

Valeant Pharmaceuticals Intl Rating Reiterated by JPMorgan Chase & Co. (VRX)

Valeant Pharmaceuticals Intl (NYSE:VRX)Shares of Valeant Pharmaceuticals Intl (NYSE:VRX) opened at 133.23 on Wednesday. Valeant Pharmaceuticals Intl has a one year low of $71.99 and a one year high of $153.10. The stock has a 50-day moving average of ... [Published American Banking News - 2 hours ago]
First reported 14 hours ago - Updated 11 hours ago - 3 reports

Can Endo's CEO Do An Encore Of His Playbook At Valeant? Guru Funds Think So.

By Ganaxi Small Cap Movers :Shares of Endo International ( ENDP ), a Dublin, Ireland-based global specialty healthcare company, have been taken down huge in this correction (see chart). They closed yesterday 25% below just last month's highs, and were ... [Published BioPortfolio - 11 hours ago]
First reported Apr 22 2014 - Updated 17 hours ago - 36 reports

Fitch Places Allergan's Ratings on Negative Watch

CHICAGO--(BUSINESS WIRE)--Apr. 23, 2014-- Fitch Ratings has placed the ratings for Allergan Inc. (Allergan), including the 'A+' Issuer Default Rating (IDR), on Rating Watch Negative. The rating action stems from Valeant Pharmaceuticals International Inc.'s ... [Published BusinessWeek - 17 hours ago]
First reported 22 hours ago - Updated 18 hours ago - 4 reports

The Dark Side Of Bill Ackman's Big, New Deal

It's a monster deal with a fair amount of complication and $45 billion on the line — hedge fund manager Bill Ackman is teaming up with pharmaceutical company, Valeant (VRX), to acquire one of its competitors, Botox-maker Allergan (AGN). Together, ... [Published Clusterstock - 18 hours ago]
First reported Apr 23 2014 - Updated 22 hours ago - 7 reports

Valeant Pharmaceuticals Announces Nominations For Board Of Directors

PR NewswireLAVAL Quebec April 23 2014LAVAL Quebec April 23 2014 /PRNewswire/ -- Valeant Pharmaceuticals International Inc. (NYSE: VRX and TSX: VRX) announced today its nominees to stand for election to the Board of Directors at its annual meeting of shareholders ... [Published PharmiWeb - 22 hours ago]
First reported Apr 22 2014 - Updated 23 hours ago - 77 reports

Ackman: No Front Running On Allergan

Valeant Pharmaceuticals (VRX) which has teamed with activist investor William Ackman to make a $46 billion bid for drug maker Allergan (AGN).  The hostile offer was Tuesday morning. As part of its alliance with Valeant, Ackman’s firm Pershing Square acquired ... [Published BARRONS.com Focus on Funds - 23 hours ago]
First reported Apr 22 2014 - Updated Apr 23 2014 - 10 reports

CANADA STOCKS-CP outlook, Valeant deal inject cheer into TSX

* TSX closes up 62.29 points, or 0.43 percent, at 14,555.97* Valeant soars after bid for Botox maker; CP Rail up oncheery outlook(Adds fund manager comment, updates prices to close)By Alastair SharpTORONTO, April 22 (Reuters) - Canada's main stock in ... [Published Reuters - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 23 2014 - 13 reports

Europe shares close higher as pharma stocks surge

European shares closed higher on Tuesday, with merger and acquisition activity starting a shortened trading week on a positive note.The pan-European FTSEurofirst 300 Index provisionally closed higher by 1.4 percent at 1,346.94 points on Tuesday, with ... [Published StoxPlus.com - Apr 23 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 218 reports

Canadian taxpayer subsidizing Valeant bid for Allergan: Andrew McCreath

ANALYSIS:  Hedge fund manager and BNN markets commentator Andrew McCreath explains where the cost savings will come from if Valeant acquires Allergan. He also argues that Canadian taxpayers are subsidizing Valeant’s acquisition spree.Since acquiring Biovail ... [Published Business News Network - Apr 22 2014]

Quotes

...Michael Pearson, chairman and chief executive officer of Valeant, said: "This proposal represents an undeniable opportunity to create extraordinary value for both Allergan and Valeant shareholders by establishing an unrivaled platform with leading positions in ophthalmology, dermatology, aesthetics, dental and the emerging markets." Allergan's board of directors is now considering the terms of the acquisition and will take a course of action that it believes will best serve its...
Is "an unusually large 7-for-1 stock split" exciting news? Ehhh. Also "Apple expanded its buyback program to $90 billion from $60 billion because it views its shares as undervalued" ; I mean, soon they'll be trading under $100 a share, how can you not buy more? Anyway I'll just assume the extra money is, like, in lieu of any future...
Perhaps hoping to flush out any other interested parties, Allergan said its plan "is not intended to prevent an acquisition of the company on terms that the Board considers favourable [but] aims to provide the board with adequate time to fully assess any proposal"
Valeant to launch a $45.6 billion takeover of Botox maker Allergan, warned drugmakers Tuesday that he plans to go on a little buying spree. "This is not the last deal we're going to ..."

More Content

All (1270) | News (1063) | Reports (0) | Blogs (166) | Audio/Video (4) | Fact Sheets (2) | Press Releases (28)
sort by: Date | Relevance
Zimmer to Buy Biomet for $13.35 Billion [Published Gnom.es - 25 mins ago]
Allergan confirms receipt of Valeant Pharmaceut... [Published Zenopa - 39 mins ago]
TSX ends slightly lower as banks weigh Valeant ... [Published Big News Network - 41 mins ago]
Valeant Pharmac. (VRX) Showing Bullish Technica... [Published MarketIntelligenceCenter.com - 1 hour ago]
Levine on Wall Street: Allergan Allegations [Published Bloomberg View - 1 hour ago]
CANADA STOCKS-TSX set to open higher after resu... [Published Reuters - 1 hour ago]
Cutting Costs and Plotting Mergers [Published DealBook - 1 hour ago]
TSX set to open higher after results from Apple... [Published 4 Traders - 1 hour ago]
Allergan resists Valeant's advances [Published PMLive - 2 hours ago]
Allergan adopts poison pill defense in Valeant ... [Published Big News Network - 2 hours ago]
Valeant to Replace Three Board Members Allergan... [Published Big News Network - 2 hours ago]
Allergan deploys poison pill defence on Valeant... [Published Big News Network - 2 hours ago]
Ackman isn’t stopping with Botox takeover [Published Big News Network - 2 hours ago]
Valeant Pharmaceuticals Intl Rating Reiterated ... [Published American Banking News - 2 hours ago]
Movers & shakers: April 24, 2014 [Published TheDeal.com - 4 hours ago]
Allergan's ratings on negative watch [Published Stock Market Wire - 4 hours ago]
US stock market daily report (April 23, 2014, W... [Published Stock Markets Review - 5 hours ago]
Almirall Quietly Building A Better Business [Published Seeking Alpha - 8 hours ago]
How Obamacare Could Kill Your Kids, and Their K... [Published Town Hall - 8 hours ago]
Allergan : Bill Ackman’s Got A Fever And The On... [Published 4 Traders - 9 hours ago]
Shareholder activism your friend: Cramer [Published Stockboard Media Inc. - 10 hours ago]
Canadian stock market declines amid weak China ... [Published Individual.com - 10 hours ago]
Strict Cost-Cutters Who Want to Spend $45 Billi... [Published Columbus - 10 hours ago]
Benzinga's M&A Chatter for Wednesday April 23, ... [Published DailyMe.Com - 11 hours ago]
Strict Cost-Cutters Who Want to Spend $45 Billi... [Published DealBook - 11 hours ago]
Can Endo's CEO Do An Encore Of His Playbook At ... [Published BioPortfolio - 11 hours ago]
Allergan deploys 'poison pill' defence on Valea... [Published Pharma Times - 12 hours ago]
Can Endo's CEO Do An Encore Of His Playbook At ... [Published Citybizlist - 12 hours ago]
Benzinga's M&A Chatter for Wednesday April 23, ... [Published Benzinga.com - 12 hours ago]
Valeant Pharmaceuticals Intl Upgraded to Buy at... [Published American Banking News - 12 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Valeant Pharmac. (VRX) Showing Bullish Technica... [Published MarketIntelligenceCenter.com - 1 hour ago]
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center  are highlighting two trades on Valeant Pharmac. (VRX) today after it closed at $133.23 on Wednesday. For more conservative investors, ...
Cutting Costs and Plotting Mergers [Published DealBook - 1 hour ago]
Valeant's unusual corporate culture comes into focus. | Using Dodd-Frank to sue an auto lender. | Investors bet on live-streamed spinning classes. | Chobani gets a $750 million loan from TPG Capital. ...
Strict Cost-Cutters Who Want to Spend $45 Billi... [Published DealBook - 11 hours ago]
Valeant's chief, J. Michael Pearson, has slimmed down the company, but been an aggressive acquirer, spending more than $19 billion on companies. Valeant now has Allergan, maker of Botox, in its sights. ...
Canadian Stocks Decline in Final Half Hour as V... [Published Bloomberg via Google News - 15 hours ago]
Canadian Stocks Decline in Final Half Hour as Valeant Tumbles Bloomberg Canadian stocks fell, erasing an earlier advance in the last half hour of trading, as Valeant Pharmaceuticals International Inc. tumbled to overshadow gains among commodity shares. ...
TSX ends lower as Valeant pulls back [Published Yahoo! Health News - 15 hours ago]
By Alastair Sharp TORONTO (Reuters) - Canada's main stock index edged lower on Wednesday, with gains from some big energy producers offset by dips in heavyweight banks and a pullback in Valeant Pharmaceuticals International Inc shares after an... ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Breakingviews: A Valeant play for Allergan [Published Reuters Video: Top News - Apr 22 2014]
Breakingviews: A Valeant play for Allergan [Published Reuters Video: Business - Apr 22 2014]
Novartis And GlaxoSmithKline Doing Deals [Published Wall Street Journal What's News - Apr 22 2014]
Drivers Are Facing Higher Gasoline Prices [Published Wall Street Journal What's News - Apr 22 2014]
1

Press Releases

sort by: Date | Relevance
ALLERGAN INVESTOR ALERT BY THE FORMER ATTORNEY ... [Published Financial Services - Apr 23 2014]
Health Care Stocks Technical Coverage -- Resear... [Published Financial Services - Apr 09 2014]
Meda and Valeant terminates joint ventures [Published GlobeNewswire: Advertising News - Apr 07 2014]
Reviewing the Top Health Care Equities -- Resea... [Published Financial Services - Mar 21 2014]
Valeant Pharmaceuticals Reports Fourth Quarter ... [Published Financial Services - Feb 27 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.